2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
82
Endocrine
3
Other
1
NET
1
Lymphoid
1
Breast
1
Conditions
Breast Neoplasms
13110
Triple Negative Breast Neoplasms
1145
Neoplasms
748
Ovarian Neoplasms
676
Neoplasm Metastasis
588
Lung Neoplasms
581
Colorectal Neoplasms
576
Prostatic Neoplasms
559
Carcinoma, Non-Small-Cell Lung
533
Pancreatic Neoplasms
380
Melanoma
366
Stomach Neoplasms
349
Colonic Neoplasms
330
Motor Activity
285
Breast Neoplasms, Male
285
Carcinoma, Intraductal, Noninfiltrating
277
Uterine Cervical Neoplasms
265
Head and Neck Neoplasms
265
Endometrial Neoplasms
254
Carcinoma, Renal Cell
215
Sarcoma
202
Urinary Bladder Neoplasms
192
Squamous Cell Carcinoma of Head and Neck
190
Lymphedema
190
Breast Carcinoma In Situ
189
Esophageal Neoplasms
188
Brain Neoplasms
183
Fatigue
166
Carcinoma, Ovarian Epithelial
151
Breast Cancer Female
148
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Hyperplasia
×
Breast
×
Clear all
NCT02015806
2016-01-11
REMIND
Brigham and Women's Hospital
Phase NA
Completed
53,480 enrolled